Regulatory considerations for direct-to-consumer medical testing
A joint presentation with Anthony Harnden and Joseph Burt. Professor Anthony Harnden is the chair of the Medicines and Healthcare products Regulatory Agency (MHRA). He is professor of primary care at the University of Oxford and until December 2024, was a registrant council member of the General Medical Council and Chair of the Remuneration Committee. He was also deputy chair of the Joint Committee on Vaccination and Immunisation (JCVI), playing a key role in ensuring public trust and patient safety during the distribution of the Covid vaccine. Anthony has over 40 years of experience working for NHS, mostly as a general practitioner in Wheatley, Oxfordshire. He is particularly focused on protecting patient safety through robust surveillance and embracing riskproportionate regulation to maintain the UK as a global regulator of excellence. Joseph is an experienced Quality and Regulatory professional who is enthusiastic about delivering innovative, safe and groundbreaking medical devices to the benefit of patients and for use by healthcare practitioners. With over 25 years of experience working in small to global medical device companies, he has developed several in vitro diagnostic medical devices, including the approval of developed devices with multiple regulatory jurisdictions. He is passionate about bringing positive outcomes through though the use of innovative medical technologies and a champion for early diagnosis for preventative healthcare. Joseph is the Head of IVD and General Medical Devices with the MHRA. This talk was recorded at our event ‘Direct-to-Consumer Medical Testing: Exploring Opportunities & Challenges’ which took place at St Anne’s College, University of Oxford on Tuesday 5th May 2026.